Hafezparast M, Klocke R, Ruhrberg C, Marquardt A, Ahmad-Annuar A, Bowen S, Lalli G, Witherden AS, Hummerich H, Nicholson S, Morgan PJ, Oozageer R, Priestley JV, Averill S, King VR, Ball S, Peters J, Toda T, Yamamoto A, Hiraoka Y, Augustin M, Korthaus D, Wattler S, Wabnitz P, Dickneite C, Lampel S, Boehme F, Peraus G, Popp A, Rudelius M, Schlegel J, Fuchs H, Hrabe de Angelis M, Schiavo G, Shima DT, Russ AP, Stumm G, Martin JE, Fisher EM. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science. 2003 May 2;300(5620):808-12. PubMed Abstract

REAGENTS/MATERIAL:

Antibodies used in this study: R325 (sc-9115, Santa Cruz) for cytoplasmic dynein heavy chain detection in WB, IHC, IP; MAB1618 (Chemicon) for cytoplasmic dynein intermediate chain in WB, IHC, IP; D5167, Clone 70.1, Sigma) for cytoplasmic dynein intermediate chain in IHC; NCL-SOD1 (Nococastra) for superoxice dismutase 1 (CuZn) (Clone SD-G6, S2147, Sigma) in IHC; Z334 (DAKO) for GFAP in IHC; Clone 2F11 (DAKO) for neurofilament in whole mount in situ hybridization; AB1981 (Chemicon) for neurofilament in IHC; Mab377 (Chemicon) for NeuN in IHC; Z0458 (DAKO) for CDK5 in IHC; TUJ1 (BabCo) for Beta III tubulin in whole mount in situ hybridization; CA1137 (affiniti) for CGRP in nerve ligiation; Asy3 (Biometra) for Synaptophysin in nerve ligiation; A1582 (Chemicon) for choline acetytransferase in nerve ligation.